<DOC>
	<DOCNO>NCT02616887</DOCNO>
	<brief_summary>Based know efficacy ablative single dose SBRT VMAT technique various solid tumor , investigator design study ass feasibility SBRT select patient spine metastasis .</brief_summary>
	<brief_title>Study Image-Guided SBRT Vertebral Metastases</brief_title>
	<detailed_description>This prospective , phase 2 study . The main objective assess acute late side effect single fraction SBRT select patient vertebral metastasis study local control disease treat site . The schedule 1 fraction 18 Gy deliver one day Volumetric Modulated Arc Therapy ( VMAT ) Flattening filter-free ( FFF ) beam .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Age ≥ 18years . WHO performance status ≤ 2 ( ECOG KPS ) . Histologicallyproven primary cancer disease . Metastatic disease spine , C1 Sacrum . A maximum number 5 site . Each separate site may maximal involvement 2 contiguous vertebral body . Epidural compression eligible least 3 mm gap spinal cord edge epidural lesion , unless patient underwent decompression surgery . A paraspinal mass ≤ 5 cm . Minimal residual tumor surgery Metastases district body allow . Informed consent . &gt; 50 % loss vertebral body height . Prior radiation interested spine . Patients MRI spine medically contraindicate . Patients allergic contrast use MRIs CT scan premedicated use contrast .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>